Actualités Pharmathene, (delisted) - PIP | Actions American Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on May 10, 2017 Registration No. &nb...

Statement of Ownership (sc 13g)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

(25)

OMB APPROVAL OMB...

Securities Registration (section 12(b)) (8-a12b)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by PharmAthene, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

PharmAthene Reports First Quarter 2017 Financial and Operational Results

PharmAthene Reports First Quarter 2017 Financial and Operational Results PR Newswire ANNAPOLIS, Md., May 3, 2017 ANNAPOLIS, Md., May 3, 2017...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by PharmAthene, Inc. Pursuant to Rule 425 under the Securities Act of...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by PharmAthene, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-215891 ...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmathene, (delisted) (PIP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

PIP Actualités

Securities Registration: Employee Benefit Plan (s-8)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

(25)

Securities Registration (section 12(b)) (8-a12b)

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

PharmAthene Reports First Quarter 2017 Financial and Operational Results

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Notice of Effectiveness (effect)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Notice of Effectiveness (effect)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmathene, (delisted) (PIP) Actualités

Pharmathene, (delisted) (PIP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

PIP Actualités

Securities Registration: Employee Benefit Plan (s-8)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

(25)

Securities Registration (section 12(b)) (8-a12b)

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

PharmAthene Reports First Quarter 2017 Financial and Operational Results

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Notice of Effectiveness (effect)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Notice of Effectiveness (effect)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités